UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Analysis of the B cell receptor repertoire in six immune-mediated diseases

Nature (London), 2019-10, Vol.574 (7776), p.122-126

2019

Volltextzugriff (PDF)

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

Annals of the Rheumatic Diseases, 2011-03, Vol.70 (3), p.414-422

2011

Volltextzugriff (PDF)

The alternative complement pathway in ANCA‐associated vasculitis: further evidence and a meta‐analysis

Clinical and experimental immunology, 2020-12, Vol.202 (3), p.394-402

2020

Volltextzugriff (PDF)

Deoxyspergualin in relapsing and refractory Wegener’s granulomatosis

Annals of the rheumatic diseases, 2009-07, Vol.68 (7), p.1125-1130

2009

Volltextzugriff (PDF)

Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK

Rheumatology (Oxford, England), 2011-10, Vol.50 (10), p.1916-1920

2011

Volltextzugriff (PDF)

Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)

Annals of the rheumatic diseases, 2016-02, Vol.75 (2), p.396-401

2016

Volltextzugriff (PDF)

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis

Annals of the rheumatic diseases, 2009-01, Vol.68 (1), p.103-106

2009

Volltextzugriff (PDF)

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis

Rheumatology (Oxford, England), 2012-04, Vol.51 (4), p.634-643

2012

Volltextzugriff (PDF)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials

Rheumatology (Oxford, England), 2011-12, Vol.50 (12), p.2214-2222

2011

Volltextzugriff (PDF)

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis

Rheumatology (Oxford, England), 2011-05, Vol.50 (5), p.899-905

2011

Volltextzugriff (PDF)

The cost-effectiveness of mycophenolate mofetil as firstline therapy in active lupus nephritis

Rheumatology (Oxford, England), 2007-07, Vol.46 (7), p.1096-1101

2007

Volltextzugriff (PDF)

Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases

Autoimmunity reviews, 2011-04, Vol.10 (6), p.341-352

2011

Volltextzugriff (PDF)

Long‐term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re‐treatment

Arthritis and rheumatism, 2006-09, Vol.54 (9), p.2970-2982

2006

Volltextzugriff (PDF)

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Annals of the rheumatic diseases, 2006-07, Vol.65 (7), p.841-844

2006

Volltextzugriff (PDF)

Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study

Scandinavian journal of rheumatology, 2013-01, Vol.42 (3), p.211-214

2013

Volltextzugriff (PDF)

Infliximab improves endothelial dysfunction in systemic vasculitis a model of vascular inflammation

Circulation (New York, N.Y.), 2004-04, Vol.109 (14), p.1718-1723

2004

Volltextzugriff (PDF)

A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe

Clinical and experimental rheumatology, 2008-11, Vol.26 (6), p.1027

2008

Volltextzugriff (PDF)

Rituximab in Churg-Strauss syndrome

Annals of the rheumatic diseases, 2006-04, Vol.65 (4), p.557-559

2006

Volltextzugriff (PDF)

Rituximab for ANCA-associated vasculitis in the setting of severe infection

Scandinavian journal of rheumatology, 2013-01, Vol.42 (3), p.207-210

2013

Volltextzugriff (PDF)

Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis

Clinical and experimental immunology, 1990-11, Vol.82 (2), p.227-232

1990

Volltextzugriff (PDF)

Remission induction in Behçet's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H

British journal of rheumatology, 2003-12, Vol.42 (12), p.1539-1544

2003

Volltextzugriff (PDF)

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial

Annals of internal medicine, 2009-05, Vol.150 (10), p.670

2009

Volltextzugriff (PDF)

Inflammation and arterial stiffness in systemic vasculitis: A model of vascular inflammation

Arthritis and rheumatism, 2004-02, Vol.50 (2), p.581-588

2004

Volltextzugriff (PDF)

Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity

Clinical and experimental rheumatology, 2013-01, Vol.31 (1 Suppl 75), p.S38

2013

Volltextzugriff (PDF)

Anti‐idiotypes against anti‐neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis

Clinical and experimental immunology, 1991-02, Vol.83 (2), p.298-303

1991

Volltextzugriff (PDF)

1 – 25 von 435

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(410)
Mit Volltextzugriff
(378)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(330)
Life Sciences & Biomedicine
(291)
Humans
(238)
Male
(139)
Female
(131)
Biological And Medical Sciences
(121)
Medical Sciences
(106)
Middle Aged
(102)
Aged
(80)
Adult
(71)
Rheumatology
(54)
Physical Sciences
(46)
Treatment Outcome
(44)
Medicin Och Hälsovetenskap
(42)
Animals
(35)
Vasculitis
(35)
Immunosuppressive Agents - Therapeutic Use
(34)
Vasculitis - Immunology
(32)
Patients
(31)
Meteorology & Atmospheric Sciences
(30)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Analysis of the B cell receptor repertoire in six immune-mediated diseases

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

The alternative complement pathway in ANCA‐associated vasculitis: further evidence and a meta‐analysis

Deoxyspergualin in relapsing and refractory Wegener’s granulomatosis

Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK

Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis

The cost-effectiveness of mycophenolate mofetil as firstline therapy in active lupus nephritis

Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases

Long‐term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re‐treatment

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study

Infliximab improves endothelial dysfunction in systemic vasculitis a model of vascular inflammation

A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe

Rituximab in Churg-Strauss syndrome

Rituximab for ANCA-associated vasculitis in the setting of severe infection

Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis

Remission induction in Behçet's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial

Inflammation and arterial stiffness in systemic vasculitis: A model of vascular inflammation

Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity

Anti‐idiotypes against anti‐neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis

Suchergebnisse filtern